# Calyptus Pharmaceuticals, Inc. — Form D

Calyptus Pharmaceuticals, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-17. The offering totals $3.7M, of which $2.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2018-05-17
- Form: D
- Accession: 0001741047-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $2.9M
- Remaining: $800K
- Minimum investment: $25K
- Investors: 30
- Date of first sale: 2018-05-04
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-312709

## Issuer

- Name: Calyptus Pharmaceuticals, Inc.
- CIK: 0001741047
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 174 NASSAU ST #364, PRINCETON, NJ, 08542
- Phone: 908-720-6049

## Officers, directors & promoters (9)

| Name | Role | Location |
| --- | --- | --- |
| Sinharoy K Shubhayu | Director | Princeton, NJ |
| Sujeet K Singh | Director | Princeton, NJ |
| Puiho K Yuen | Director | Princeton, NJ |
| Sinharoy K Shubhayu | Executive Officer | Princeton, NJ |
| Sujeet K Singh | Executive Officer | Princeton, NJ |
| Puiho K Yuen | Executive Officer | Princeton, NJ |
| Sinharoy K Shubhayu | Promoter | Princeton, NJ |
| Sujeet K Singh | Promoter | Princeton, NJ |
| Puiho K Yuen | Promoter | Princeton, NJ |

## More

- [CIK 1741047 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1741047&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001741047-18-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.